Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Jan 1;99(1):19–23. doi: 10.1172/JCI119127

Mutation of human keratin 18 in association with cryptogenic cirrhosis.

N O Ku 1, T L Wright 1, N A Terrault 1, R Gish 1, M B Omary 1
PMCID: PMC507762  PMID: 9011570

Abstract

Mutations in 11 of the more than 20 keratin intermediate filaments cause several epidermal and oral associated diseases. No disease-associated mutations have been described in keratin 8 or 18 (K8/18) which are the major keratin pair in simple-type epithelia, as found in the liver, pancreas, and intestine. However, transgenic mice that express mutant keratin 18 develop chronic hepatitis, and have an increased susceptibility to drug-induced hepatotoxicity. Also, ectopic expression of epidermal K14 in mouse liver results in chronic hepatitis, and disruption of mouse K8 leads to embryo lethality with extensive liver hemorrhage. We tested if patients with liver disease of unknown cause may harbor mutations in K18. We describe a his127-->leu (H127L) K18 mutation in a patient with cryptogenic cirrhosis that is germline transmitted. The K18 H127L isolated from the liver explant, or after expression in bacteria, showed an altered migration on two-dimensional gel analysis as compared with normal human liver or bacterially expressed K18. Electron microscopy of in vitro assembled K18 H127L and wild type K8 showed an assembly defect as compared with normal K8/18 assembly. Our results suggest that mutations in K18 may be predispose to, or result in cryptogenic cirrhosis in humans.

Full Text

The Full Text of this article is available as a PDF (320.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albers K. M., Davis F. E., Perrone T. N., Lee E. Y., Liu Y., Vore M. Expression of an epidermal keratin protein in liver of transgenic mice causes structural and functional abnormalities. J Cell Biol. 1995 Jan;128(1-2):157–169. doi: 10.1083/jcb.128.1.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bader B. L., Jahn L., Franke W. W. Low level expression of cytokeratins 8, 18 and 19 in vascular smooth muscle cells of human umbilical cord and in cultured cells derived therefrom, with an analysis of the chromosomal locus containing the cytokeratin 19 gene. Eur J Cell Biol. 1988 Dec;47(2):300–319. [PubMed] [Google Scholar]
  3. Baribault H., Price J., Miyai K., Oshima R. G. Mid-gestational lethality in mice lacking keratin 8. Genes Dev. 1993 Jul;7(7A):1191–1202. doi: 10.1101/gad.7.7a.1191. [DOI] [PubMed] [Google Scholar]
  4. Bowden P. E., Haley J. L., Kansky A., Rothnagel J. A., Jones D. O., Turner R. J. Mutation of a type II keratin gene (K6a) in pachyonychia congenita. Nat Genet. 1995 Jul;10(3):363–365. doi: 10.1038/ng0795-363. [DOI] [PubMed] [Google Scholar]
  5. Coulombe P. A., Hutton M. E., Letai A., Hebert A., Paller A. S., Fuchs E. Point mutations in human keratin 14 genes of epidermolysis bullosa simplex patients: genetic and functional analyses. Cell. 1991 Sep 20;66(6):1301–1311. doi: 10.1016/0092-8674(91)90051-y. [DOI] [PubMed] [Google Scholar]
  6. Darmon M. Y., Sémat A., Darmon M. C., Vasseur M. Sequence of a cDNA encoding human keratin No 10 selected according to structural homologies of keratins and their tissue-specific expression. Mol Biol Rep. 1987;12(4):277–283. doi: 10.1007/BF00444680. [DOI] [PubMed] [Google Scholar]
  7. Domenjoud L., Jorcano J. L., Breuer B., Alonso A. Synthesis and fate of keratins 8 and 18 in nonepithelial cells transfected with cDNA. Exp Cell Res. 1988 Dec;179(2):352–361. doi: 10.1016/0014-4827(88)90274-1. [DOI] [PubMed] [Google Scholar]
  8. Figlewicz D. A., Krizus A., Martinoli M. G., Meininger V., Dib M., Rouleau G. A., Julien J. P. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum Mol Genet. 1994 Oct;3(10):1757–1761. doi: 10.1093/hmg/3.10.1757. [DOI] [PubMed] [Google Scholar]
  9. Fuchs E., Chan Y. M., Paller A. S., Yu Q. C. Cracks in the foundation: keratin filaments and genetic disease. Trends Cell Biol. 1994 Sep;4(9):321–326. doi: 10.1016/0962-8924(94)90233-x. [DOI] [PubMed] [Google Scholar]
  10. Fuchs E., Coulombe P. A. Of mice and men: genetic skin diseases of keratin. Cell. 1992 Jun 12;69(6):899–902. doi: 10.1016/0092-8674(92)90607-e. [DOI] [PubMed] [Google Scholar]
  11. Fuchs E., Weber K. Intermediate filaments: structure, dynamics, function, and disease. Annu Rev Biochem. 1994;63:345–382. doi: 10.1146/annurev.bi.63.070194.002021. [DOI] [PubMed] [Google Scholar]
  12. Kodali V. P., Gordon S. C., Silverman A. L., McCray D. G. Cryptogenic liver disease in the United States: further evidence for non-A, non-B, and non-C hepatitis. Am J Gastroenterol. 1994 Oct;89(10):1836–1839. [PubMed] [Google Scholar]
  13. Ku N. O., Michie S. A., Soetikno R. M., Resurreccion E. Z., Broome R. L., Oshima R. G., Omary M. B. Susceptibility to hepatotoxicity in transgenic mice that express a dominant-negative human keratin 18 mutant. J Clin Invest. 1996 Aug 15;98(4):1034–1046. doi: 10.1172/JCI118864. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ku N. O., Michie S., Oshima R. G., Omary M. B. Chronic hepatitis, hepatocyte fragility, and increased soluble phosphoglycokeratins in transgenic mice expressing a keratin 18 conserved arginine mutant. J Cell Biol. 1995 Dec;131(5):1303–1314. doi: 10.1083/jcb.131.5.1303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Ku N. O., Omary M. B. Identification of the major physiologic phosphorylation site of human keratin 18: potential kinases and a role in filament reorganization. J Cell Biol. 1994 Oct;127(1):161–171. doi: 10.1083/jcb.127.1.161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Kulesh D. A., Ceceña G., Darmon Y. M., Vasseur M., Oshima R. G. Posttranslational regulation of keratins: degradation of mouse and human keratins 18 and 8. Mol Cell Biol. 1989 Apr;9(4):1553–1565. doi: 10.1128/mcb.9.4.1553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Langbein L., Heid H. W., Moll I., Franke W. W. Molecular characterization of the body site-specific human epidermal cytokeratin 9: cDNA cloning, amino acid sequence, and tissue specificity of gene expression. Differentiation. 1993 Dec;55(1):57–71. doi: 10.1111/j.1432-0436.1993.tb00033.x. [DOI] [PubMed] [Google Scholar]
  18. Liao J., Lowthert L. A., Ghori N., Omary M. B. The 70-kDa heat shock proteins associate with glandular intermediate filaments in an ATP-dependent manner. J Biol Chem. 1995 Jan 13;270(2):915–922. doi: 10.1074/jbc.270.2.915. [DOI] [PubMed] [Google Scholar]
  19. Marchuk D., McCrohon S., Fuchs E. Remarkable conservation of structure among intermediate filament genes. Cell. 1984 Dec;39(3 Pt 2):491–498. doi: 10.1016/0092-8674(84)90456-2. [DOI] [PubMed] [Google Scholar]
  20. McLean W. H., Lane E. B. Intermediate filaments in disease. Curr Opin Cell Biol. 1995 Feb;7(1):118–125. doi: 10.1016/0955-0674(95)80053-0. [DOI] [PubMed] [Google Scholar]
  21. McLean W. H., Rugg E. L., Lunny D. P., Morley S. M., Lane E. B., Swensson O., Dopping-Hepenstal P. J., Griffiths W. A., Eady R. A., Higgins C. Keratin 16 and keratin 17 mutations cause pachyonychia congenita. Nat Genet. 1995 Mar;9(3):273–278. doi: 10.1038/ng0395-273. [DOI] [PubMed] [Google Scholar]
  22. Moll R., Franke W. W., Schiller D. L., Geiger B., Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell. 1982 Nov;31(1):11–24. doi: 10.1016/0092-8674(82)90400-7. [DOI] [PubMed] [Google Scholar]
  23. Moll R., Schiller D. L., Franke W. W. Identification of protein IT of the intestinal cytoskeleton as a novel type I cytokeratin with unusual properties and expression patterns. J Cell Biol. 1990 Aug;111(2):567–580. doi: 10.1083/jcb.111.2.567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Morley S. M., Dundas S. R., James J. L., Gupta T., Brown R. A., Sexton C. J., Navsaria H. A., Leigh I. M., Lane E. B. Temperature sensitivity of the keratin cytoskeleton and delayed spreading of keratinocyte lines derived from EBS patients. J Cell Sci. 1995 Nov;108(Pt 11):3463–3471. doi: 10.1242/jcs.108.11.3463. [DOI] [PubMed] [Google Scholar]
  25. Nozaki M., Mori M., Matsushiro A. The complete sequence of the gene encoding mouse cytokeratin 15. Gene. 1994 Jan 28;138(1-2):197–200. doi: 10.1016/0378-1119(94)90807-9. [DOI] [PubMed] [Google Scholar]
  26. Oshima R. G., Millán J. L., Ceceña G. Comparison of mouse and human keratin 18: a component of intermediate filaments expressed prior to implantation. Differentiation. 1986;33(1):61–68. doi: 10.1111/j.1432-0436.1986.tb00411.x. [DOI] [PubMed] [Google Scholar]
  27. RayChaudhury A., Marchuk D., Lindhurst M., Fuchs E. Three tightly linked genes encoding human type I keratins: conservation of sequence in the 5'-untranslated leader and 5'-upstream regions of coexpressed keratin genes. Mol Cell Biol. 1986 Feb;6(2):539–548. doi: 10.1128/mcb.6.2.539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Richard G., De Laurenzi V., Didona B., Bale S. J., Compton J. G. Keratin 13 point mutation underlies the hereditary mucosal epithelial disorder white sponge nevus. Nat Genet. 1995 Dec;11(4):453–455. doi: 10.1038/ng1295-453. [DOI] [PubMed] [Google Scholar]
  29. Rugg E. L., McLean W. H., Allison W. E., Lunny D. P., Macleod R. I., Felix D. H., Lane E. B., Munro C. S. A mutation in the mucosal keratin K4 is associated with oral white sponge nevus. Nat Genet. 1995 Dec;11(4):450–452. doi: 10.1038/ng1295-450. [DOI] [PubMed] [Google Scholar]
  30. Steinert P. M., Bale S. J. Genetic skin diseases caused by mutations in keratin intermediate filaments. Trends Genet. 1993 Aug;9(8):280–284. doi: 10.1016/0168-9525(93)90014-9. [DOI] [PubMed] [Google Scholar]
  31. Steinert P. M., Roop D. R. Molecular and cellular biology of intermediate filaments. Annu Rev Biochem. 1988;57:593–625. doi: 10.1146/annurev.bi.57.070188.003113. [DOI] [PubMed] [Google Scholar]
  32. Troyanovsky S. M., Leube R. E., Franke W. W. Characterization of the human gene encoding cytokeratin 17 and its expression pattern. Eur J Cell Biol. 1992 Oct;59(1):127–137. [PubMed] [Google Scholar]
  33. Vassar R., Coulombe P. A., Degenstein L., Albers K., Fuchs E. Mutant keratin expression in transgenic mice causes marked abnormalities resembling a human genetic skin disease. Cell. 1991 Jan 25;64(2):365–380. doi: 10.1016/0092-8674(91)90645-f. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES